Spectrascience Non Current Liabilities Total vs Common Stock Analysis

Spectrascience New financial indicator trend analysis is much more than just breaking down Spectrascience New prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Spectrascience New is a good investment. Please check the relationship between Spectrascience New Non Current Liabilities Total and its Common Stock accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Spectrascience New. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

For information on how to trade Spectrascience Stock refer to our How to Trade Spectrascience Stock guide.

Non Current Liabilities Total vs Common Stock

Non Current Liabilities Total vs Common Stock Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Spectrascience New Non Current Liabilities Total account and Common Stock. At this time, the significance of the direction appears to have significant contrarian relationship.

The correlation between Spectrascience New's Non Current Liabilities Total and Common Stock is -0.43. Overlapping area represents the amount of variation of Non Current Liabilities Total that can explain the historical movement of Common Stock in the same time period over historical financial statements of Spectrascience New, assuming nothing else is changed. The correlation between historical values of Spectrascience New's Non Current Liabilities Total and Common Stock is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Liabilities Total of Spectrascience New are associated (or correlated) with its Common Stock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Common Stock has no effect on the direction of Non Current Liabilities Total i.e., Spectrascience New's Non Current Liabilities Total and Common Stock go up and down completely randomly.

Correlation Coefficient

-0.43

Relationship Direction	Negative
Relationship Strength	Very Weak

View All Relationships

Non Current Liabilities Total

Common Stock

Most indicators from Spectrascience New's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Spectrascience New current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Spectrascience New. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

For information on how to trade Spectrascience Stock refer to our How to Trade Spectrascience Stock guide.The current year's Sales General And Administrative To Revenue is expected to grow to 228.44, whereas Selling General Administrative is forecasted to decline to about 1.4 M.

Spectrascience New fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Accounts Payable	Cash	Other Assets	Inventory	Total Liab	Common Stock	Property Plant Equipment	Other Liab	Intangible Assets	Preferred Stock Total Equity	Short Term Investments	Net Tangible Assets	Retained Earnings	Net Receivables	Short Long Term Debt	Total Current Assets	Short Term Debt	Non Current Assets Total	Non Currrent Assets Other	Long Term Debt	Non Current Liabilities Total
Total Assets		-0.2	-0.93	0.97	-0.93	0.81	-0.64	0.82	-0.92	-0.8	0.93	-0.33	0.05	-0.36	0.18	0.85	0.84	0.84	-0.83	0.8	-0.83	0.18	0.18	0.18	0.18
Other Current Liab	-0.2		0.04	-0.08	0.14	-0.3	0.25	-0.09	0.02	-0.12	-0.29	0.11	0.17	0.32	-0.06	0.17	0.18	0.16	-0.18	0.18	-0.18	-0.06	-0.06	-0.06	-0.06
Total Current Liabilities	-0.93	0.04		-0.97	0.93	-0.61	0.39	-0.92	1.0	0.93	-0.86	0.5	-0.2	0.27	-0.41	-0.93	-0.88	-0.92	0.92	-0.87	0.92	-0.41	-0.41	-0.41	-0.41
Total Stockholder Equity	0.97	-0.08	-0.97		-0.9	0.66	-0.5	0.91	-0.96	-0.89	0.88	-0.31	0.25	-0.2	0.18	0.94	0.93	0.91	-0.92	0.9	-0.92	0.18	0.18	0.18	0.18
Accounts Payable	-0.93	0.14	0.93	-0.9		-0.78	0.55	-0.79	0.93	0.87	-0.83	0.57	0.1	0.47	-0.45	-0.83	-0.76	-0.77	0.78	-0.79	0.78	-0.45	-0.45	-0.45	-0.45
Cash	0.81	-0.3	-0.61	0.66	-0.78		-0.87	0.4	-0.59	-0.43	0.73	-0.34	-0.49	-0.63	0.12	0.47	0.47	0.51	-0.48	0.43	-0.48	0.12	0.12	0.12	0.12
Other Assets	-0.64	0.25	0.39	-0.5	0.55	-0.87		-0.22	0.38	0.21	-0.59	0.24	0.33	0.24	0.23	-0.3	-0.31	-0.35	0.42	-0.35	0.42	0.23	0.23	0.23	0.23
Inventory	0.82	-0.09	-0.92	0.91	-0.79	0.4	-0.22		-0.92	-0.91	0.74	-0.34	0.42	-0.09	0.29	0.9	0.86	0.81	-0.88	0.91	-0.88	0.29	0.29	0.29	0.29
Total Liab	-0.92	0.02	1.0	-0.96	0.93	-0.59	0.38	-0.92		0.95	-0.84	0.5	-0.2	0.26	-0.42	-0.94	-0.89	-0.92	0.92	-0.89	0.92	-0.42	-0.42	-0.42	-0.42
Common Stock	-0.8	-0.12	0.93	-0.89	0.87	-0.43	0.21	-0.91	0.95		-0.64	0.47	-0.27	0.18	-0.43	-0.96	-0.89	-0.85	0.9	-0.94	0.9	-0.43	-0.43	-0.43	-0.43
Property Plant Equipment	0.93	-0.29	-0.86	0.88	-0.83	0.73	-0.59	0.74	-0.84	-0.64		-0.32	0.12	-0.26	0.17	0.69	0.7	0.78	-0.72	0.62	-0.72	0.17	0.17	0.17	0.17
Other Liab	-0.33	0.11	0.5	-0.31	0.57	-0.34	0.24	-0.34	0.5	0.47	-0.32		0.25	0.29	-0.77	-0.28	-0.1	-0.33	0.38	-0.32	0.38	-0.77	-0.77	-0.77	-0.77
Intangible Assets	0.05	0.17	-0.2	0.25	0.1	-0.49	0.33	0.42	-0.2	-0.27	0.12	0.25		0.79	-0.31	0.33	0.37	0.3	-0.38	0.37	-0.38	-0.31	-0.31	-0.31	-0.31
Preferred Stock Total Equity	-0.36	0.32	0.27	-0.2	0.47	-0.63	0.24	-0.09	0.26	0.18	-0.26	0.29	0.79		-0.56	-0.12	-0.09	-0.12	-0.03	0.01	-0.03	-0.56	-0.56	-0.56	-0.56
Short Term Investments	0.18	-0.06	-0.41	0.18	-0.45	0.12	0.23	0.29	-0.42	-0.43	0.17	-0.77	-0.31	-0.56		0.22	0.07	0.24	-0.16	0.15	-0.16	1.0	1.0	1.0	1.0
Net Tangible Assets	0.85	0.17	-0.93	0.94	-0.83	0.47	-0.3	0.9	-0.94	-0.96	0.69	-0.28	0.33	-0.12	0.22		0.98	0.91	-0.95	0.96	-0.95	0.22	0.22	0.22	0.22
Retained Earnings	0.84	0.18	-0.88	0.93	-0.76	0.47	-0.31	0.86	-0.89	-0.89	0.7	-0.1	0.37	-0.09	0.07	0.98		0.92	-0.92	0.92	-0.92	0.07	0.07	0.07	0.07
Net Receivables	0.84	0.16	-0.92	0.91	-0.77	0.51	-0.35	0.81	-0.92	-0.85	0.78	-0.33	0.3	-0.12	0.24	0.91	0.92		-0.94	0.83	-0.94	0.24	0.24	0.24	0.24
Short Long Term Debt	-0.83	-0.18	0.92	-0.92	0.78	-0.48	0.42	-0.88	0.92	0.9	-0.72	0.38	-0.38	-0.03	-0.16	-0.95	-0.92	-0.94		-0.95	1.0	-0.16	-0.16	-0.16	-0.16
Total Current Assets	0.8	0.18	-0.87	0.9	-0.79	0.43	-0.35	0.91	-0.89	-0.94	0.62	-0.32	0.37	0.01	0.15	0.96	0.92	0.83	-0.95		-0.95	0.15	0.15	0.15	0.15
Short Term Debt	-0.83	-0.18	0.92	-0.92	0.78	-0.48	0.42	-0.88	0.92	0.9	-0.72	0.38	-0.38	-0.03	-0.16	-0.95	-0.92	-0.94	1.0	-0.95		-0.16	-0.16	-0.16	-0.16
Non Current Assets Total	0.18	-0.06	-0.41	0.18	-0.45	0.12	0.23	0.29	-0.42	-0.43	0.17	-0.77	-0.31	-0.56	1.0	0.22	0.07	0.24	-0.16	0.15	-0.16		1.0	1.0	1.0
Non Currrent Assets Other	0.18	-0.06	-0.41	0.18	-0.45	0.12	0.23	0.29	-0.42	-0.43	0.17	-0.77	-0.31	-0.56	1.0	0.22	0.07	0.24	-0.16	0.15	-0.16	1.0		1.0	1.0
Long Term Debt	0.18	-0.06	-0.41	0.18	-0.45	0.12	0.23	0.29	-0.42	-0.43	0.17	-0.77	-0.31	-0.56	1.0	0.22	0.07	0.24	-0.16	0.15	-0.16	1.0	1.0		1.0
Non Current Liabilities Total	0.18	-0.06	-0.41	0.18	-0.45	0.12	0.23	0.29	-0.42	-0.43	0.17	-0.77	-0.31	-0.56	1.0	0.22	0.07	0.24	-0.16	0.15	-0.16	1.0	1.0	1.0

Click cells to compare fundamentals

Spectrascience New Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

When determining whether Spectrascience New is a strong investment it is important to analyze Spectrascience New's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Spectrascience New's future performance. For an informed investment choice regarding Spectrascience Stock, refer to the following important reports:

How To Invest In Spectrascience

Details

Is Spectrascience Stock a good investment?

Details

What is Spectrascience New's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Spectrascience New. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

For information on how to trade Spectrascience Stock refer to our How to Trade Spectrascience Stock guide.

You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Spectrascience New. If investors know Spectrascience will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Spectrascience New listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.01)

Return On Assets

(0.92)

The market value of Spectrascience New is measured differently than its book value, which is the value of Spectrascience that is recorded on the company's balance sheet. Investors also form their own opinion of Spectrascience New's value that differs from its market value or its book value, called intrinsic value, which is Spectrascience New's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Spectrascience New's market value can be influenced by many factors that don't directly affect Spectrascience New's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Spectrascience New's value and its price as these two are different measures arrived at by different means. Investors typically determine if Spectrascience New is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Spectrascience New's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Spectrascience Non Current Liabilities Total vs Common Stock Analysis

Non Current Liabilities Total vs Common Stock

Non Current Liabilities Total vs Common Stock Correlation Analysis

Correlation Coefficient

Non Current Liabilities Total

Common Stock

Spectrascience New fundamental ratios Correlations

Spectrascience New Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Liab	+ 1.0	Total Current Liabilities
Non Current Assets Total	+ 1.0	Short Term Investments
Non Currrent Assets Other	+ 1.0	Short Term Investments
Long Term Debt	+ 1.0	Short Term Investments
Non Current Liabilities Total	+ 1.0	Short Term Investments
Short Term Debt	+ 1.0	Short Long Term Debt

Total Stockholder Equity	- 0.97	Total Current Liabilities
Net Tangible Assets	- 0.96	Common Stock
Total Liab	- 0.96	Total Stockholder Equity
Short Term Debt	- 0.95	Total Current Assets
Total Current Assets	- 0.95	Short Long Term Debt
Short Term Debt	- 0.95	Net Tangible Assets